journal article·2025-08Open access

Nanomaterial-based encapsulation of biochemicals for targeted sepsis therapy

Zhiwei Li, Bin Luo, Yisheng Chen, Lingling Wang, Yezi Liu, Jintong Jia, Mengsi Chen, Shuting Yang, Haojun Shi, Lihua Dai, Lei Huang, Changmin Wang, Jia Liu

Abstract

Sepsis is a life-threatening condition characterized by complex pathophysiology, including dysregulated immune responses, excessive inflammation, and oxidative stress, often leading to multi-organ failure and high mortality rates. Traditional therapies, such as antibiotics and anti-inflammatory agents, face significant limitations due to issues like drug resistance and inadequate immune modulation. Recent advancements in nanotechnology have introduced innovative solutions by leveraging nanomaterial-based encapsulation systems for bioactive substances, including antioxidants, anti-inflammatory agents, and immunomodulators. These systems enhance the stability, bioavailability, and targeted delivery of therapeutic agents, addressing critical challenges in sepsis management. Key nanocarriers, such as lipid nanoparticles, polymer-based systems, and plant-derived exosomes, offer controlled release mechanisms and precise targeting capabilities, enabling superior therapeutic outcomes. Moreover, nanomaterials' multifunctional properties allow for simultaneous modulation of oxidative stress, inflammation, and immune responses, presenting a synergistic approach to sepsis therapy. However, challenges persist, including the potential toxicity of nanomaterials, scalability of production, and hurdles in clinical translation. This review comprehensively explores the transformative potential of nanotechnology in reshaping sepsis treatment strategies, highlighting its role in advancing precision medicine and its prospects for overcoming current therapeutic barriers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Systemic Inflammatory Response Syndrome (SIRS): molecular pathophysiology and gene therapy10.1254/jphs.CRJ06010X ↗
2. New paradigms in sepsis: from prevention to protection of failing microcirculation10.1111/jth.13061 ↗
3. The pathogenesis of sepsis and potential therapeutic targets10.3390/ijms20215376 ↗
4. Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy10.1007/s00134-016-4577-z ↗
5. Sepsis and multiple organ failure10.1159/000102070 ↗
6. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?10.4161/viru.26516 ↗
7. The pathophysiology of sepsis and precision-medicine-based immunotherapy10.1038/s41590-023-01660-5 ↗
8. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases10.1016/j.cell.2020.03.007 ↗
9. Surface engineering of nanomaterials with polymers, biomolecules, and small ligands for nanomedicine10.3390/ma15093251 ↗
10. He · 2024
11. Nanomaterials for direct and indirect immunomodulation: a review of applications10.1016/j.ejps.2019.105139 ↗
12. A commentary on the interplay of biomaterials and cell adhesion: new insights in bone tissue regeneration10.32604/biocell.2024.055513 ↗
13. The design and application of nanomaterials as drug carriers in cancer treatment10.2174/0929867326666190816231409 ↗
14. Integrated single‐cell transcriptomics reveals the hypoxia‐induced inflammation‐cancer transformation in NASH‐derived hepatocellular carcinoma10.1111/cpr.13576 ↗
15. Transporter-targeted nano-sized vehicles for enhanced and site-specific drug delivery10.3390/cancers12102837 ↗
16. Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers10.2217/nnm.15.39 ↗
17. Recent advancements of nanomaterial-based therapeutic strategies toward sepsis: bacterial eradication, anti-inflammation, and immunomodulation10.1039/D1NR02706A ↗
18. The role of nanomaterials in translational medicine10.1021/nn201371a ↗
19. Developments and trends of nanotechnology application in sepsis: a comprehensive review based on knowledge visualization analysis10.1021/acsnano.3c10458 ↗
20. Advances in nanomaterial-based targeted drug delivery systems10.3389/fbioe.2023.1177151 ↗
21. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites10.1016/j.addr.2020.06.030 ↗
22. Nanoparticles for the treatment of wounds10.2174/1381612821666150901104601 ↗
23. Delivery of biomimetic liposomes via meningeal lymphatic vessels route for targeted therapy of Parkinson's disease10.34133/research.0030 ↗
24. Active targeting of drugs and bioactive molecules via oral administration by ligand-conjugated lipidic nanocarriers: recent advances10.1208/s12249-018-1262-2 ↗
25. Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems10.1016/j.addr.2016.02.007 ↗
26. Nanotechnological advances in cutaneous medicine10.1155/2013/808234 ↗
27. Polyphenolic phytochemicals in cancer prevention and therapy: bioavailability versus bioefficacy10.1021/acs.jmedchem.6b01026 ↗
28. Nanoestruturas contendo compostos bioativos extraídos de plantas
29. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals10.1016/j.jnutbio.2013.10.002 ↗
30. Polyphenols: extraction methods, antioxidative action, bioavailability and anticarcinogenic effects10.3390/molecules21070901 ↗
31. Establishment of a biorepository for Down syndrome: experience of the inter-institutional multidisciplinary BioBank - BioBIM10.24976/Discov.Med.202436184.85 ↗
32. Polyphenols as plant-based nutraceuticals: health effects, encapsulation, nano-delivery, and application10.3390/foods11152189 ↗
33. Circular RNAs in human diseases10.1002/mco2.699 ↗
34. Nanotechnology: current applications and future scope in food10.1002/fft2.58 ↗
35. Nanocomposites and their application in antimicrobial packaging10.3389/fchem.2024.1356304 ↗
36. Antimicrobial bio-nanocomposites and their potential applications in food packaging10.1016/j.foodcont.2020.107086 ↗
37. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies10.1002/mco2.671 ↗
38. New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication10.1002/mco2.551 ↗
39. Nanomaterials targeting macrophages in sepsis: a promising approach for sepsis management10.3389/fimmu.2022.1026173 ↗
40. A comparative analysis of vaccine lists, prices, and candidates, and the national immunization program between China and the United States10.15212/AMM-2023-0033 ↗
41. Nanocarrier-based systems for targeted and site specific therapeutic delivery10.1016/j.addr.2019.07.010 ↗
42. Recent trends in nano-based drug delivery systems for efficient delivery of phytochemicals in chemotherapy10.1039/C6RA07802H ↗
43. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: new insight for treating COVID-1910.1016/j.redox.2021.102046 ↗
44. Nanotechnology for delivery of natural therapeutic substances: a review10.1007/s10311-020-01103-9 ↗
45. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications10.1016/j.jconrel.2022.11.013 ↗
46. Nanotechnology driven improvement of smart food packaging10.1080/14328917.2022.2114667 ↗
47. Biomedical applications of silver nanoparticles: an up-to-date overview10.3390/nano8090681 ↗
48. Silver nanoparticle-based combinations with antimicrobial agents against antimicrobial-resistant clinical isolates10.3390/antibiotics11091219 ↗
49. Functionalized antimicrobial nanofibers: design criteria and recent advances10.3390/jfb12040059 ↗
50. Nanofibers for drug delivery: design and fabrication strategies10.15212/bioi-2024-0023 ↗
51. The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases10.1186/s12951-022-01343-7 ↗
52. Antibacterial carbon‐based nanomaterials10.1002/adma.201804838 ↗
53. Active delivery of antimicrobial nanoparticles into microbial cells through surface functionalization strategies10.1016/j.tifs.2020.03.008 ↗
54. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections10.1038/s41579-020-0420-1 ↗
55. Recent advances in nanomedicine for sepsis treatment10.4155/tde-2018-0009 ↗
56. Metal nanoparticles: understanding the mechanisms behind antibacterial activity10.1186/s12951-017-0308-z ↗
57. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay10.1016/j.biomaterials.2009.07.030 ↗
58. Comparative analysis of metal nanoparticles synthesized from HIBISCUS ROSA sinesis and their antibacterial activity estimation against nine pathogenic bacteria10.22159/ajpcr.2017.v10i5.17458 ↗
59. Green synthesis and potential antibacterial applications of bioactive silver nanoparticles: a review10.3390/polym14040742 ↗
60. ChemInform abstract: innovative eco‐friendly approaches for green synthesis of silver nanoparticles10.1002/chin.201539221 ↗
61. Green synthesis of potent antimicrobial silver nanoparticles using different plant extracts and their mixtures10.3390/pr7080510 ↗
62. Melatonin receptor 1B and corticosteroid receptor polymorphisms in infertile women with implantation failure and miscarriages10.31083/j.fbl2806122 ↗
63. Silver nanoparticles and their antibacterial applications10.3390/ijms22137202 ↗
64. Antimicrobial efficacy of drug blended biosynthesized colloidal gold nanoparticles from Justicia glauca against oral pathogens: a nanoantibiotic approach10.1016/j.micpath.2017.10.055 ↗
65. Shape-dependent significant physical mutilation and antibacterial mechanisms of gold nanoparticles against foodborne bacterial pathogens (Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus) at lower concentrations10.1016/j.msec.2019.110338 ↗
66. Preparation and applications of chitosan and cellulose composite materials10.1016/j.jenvman.2021.113850 ↗
67. Antimicrobial sensitisers: gatekeepers to avoid the development of multidrug-resistant bacteria10.1016/j.jconrel.2024.03.031 ↗
68. Innovative natural polymer metal nanocomposites and their antimicrobial activity10.1016/j.ijbiomac.2019.06.114 ↗
69. Natural products-based metallic nanoparticles as antimicrobial agents10.3389/fphar.2022.895616 ↗
70. Phytochemical-based nanomaterials against antibiotic-resistant bacteria: an updated review10.3390/polym15061392 ↗
71. Phenol group of terpenoids is crucial for antibacterial activity upon ion leakage10.1111/lam.13529 ↗
72. Nano-antibacterials using medicinal plant components: an overview10.3389/fmicb.2021.768739 ↗
73. A review on silver nanoparticles -green synthesis, antimicrobial action and application in textiles10.1080/15440478.2021.1964135 ↗
74. Sepsis diagnosis and treatment using nanomaterials10.1007/s13534-021-00200-0 ↗
75. The immune system's role in sepsis progression, resolution, and long‐term outcome10.1111/imr.12499 ↗
76. Modulating inflammation in a cutaneous chronic wound model by IL-10 released from collagen–silica nanocomposites via gene delivery10.1039/C7BM01024A ↗
77. Nanotechnology applications in sepsis: essential knowledge for clinicians10.3390/pharmaceutics15061682 ↗
78. Macrophage M1/M2 polarization10.1016/j.ejphar.2020.173090 ↗
79. Nanomedicine for t‐cell mediated immunotherapy
80. Applications of nanotechnology for immunology10.1038/nri3488 ↗
81. Nanoengineering facilitating the target mission: targeted extracellular vesicles delivery systems design10.1186/s12951-022-01638-9 ↗
82. Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases10.1002/mco2.660 ↗
83. Immune cell-derived extracellular vesicles for precision therapy of inflammatory-related diseases10.1016/j.jconrel.2024.03.007 ↗
84. Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization10.1002/sctm.16-0363 ↗
85. Recent advances in extracellular vesicle-based drug delivery systems for treating inflammation
86. An update on in vivo imaging of extracellular vesicles as drug delivery vehicles10.3389/fphar.2018.00169 ↗
87. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases10.3389/fimmu.2021.749192 ↗
88. Inflammatory response in microvascular endothelium in sepsis: role of oxidants10.3164/jcbn.2008026 ↗
89. Antioxidant activity of nanomaterials10.1039/C8TB00107C ↗
90. Silver nanoparticles as unique nano-drugs
91. Determination of antioxidant potential of biochemically synthesized silver nanoparticles using Aloe vera gel extract10.14719/pst.2019.6.2.532 ↗
92. Intrinsic radical species scavenging activities of tea polyphenols nanoparticles block pyroptosis in endotoxin-induced sepsis10.1021/acsnano.1c08913 ↗
93. Charting the course of blood flow: vessel-on-a-chip technologies in thrombosis studies10.20517/microstructures.2023.106 ↗
94. Antioxidants and phytochemicals
95. Solid lipid nanoparticles as carriers of natural phenolic compounds10.3390/antiox9100998 ↗
96. Nanodelivery of natural antioxidants: an anti-aging perspective10.3389/fbioe.2019.00447 ↗
97. Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock10.1097/01.shk.0000079425.52617.db ↗
98. Physiology and pathophysiology of matrix metalloproteases10.1007/s00726-010-0689-x ↗
99. ROS-based nanomedicines for anti-inflammatory therapies10.1530/REM-23-0021 ↗
100. Macrophages-regulating nanomedicines for sepsis therapy10.1016/j.cclet.2022.06.011 ↗